Evidence map›Paper›PMID 42438637›Full record

ArticleCureus2026

Multidisciplinary Treatment of Post-radiation Sarcoma in the Left Axilla Following Radiotherapy for Breast Cancer: A Case Report and Review of the Literature.

Christos Doudakmanis, Konstantinos Bouliaris, Alexis Terras, Stefania Kokkali, Georgios Agrogiannis, Stylianos Kykalos, Gerasimos Tsourouflis

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christos Doudakmanis2nd Propaedeutic Department of Surgery, Laiko General Hospital of Athens, Athens, GRC.
Konstantinos BouliarisDepartment of Surgery, University General Hospital of Larissa, Larissa, GRC.
Alexis Terras2nd Propaedeutic Department of Surgery, Laiko General Hospital of Athens, Athens, GRC.
Stefania KokkaliDepartment of Medical Oncology, Athens General Hospital Hippocrates, Athens, GRC.
Georgios AgrogiannisDepartment of Pathology, National and Kapodistrian University of Athens, Athens, GRC.
Stylianos Kykalos2nd Propaedeutic Department of Surgery, Laiko General Hospital of Athens, Athens, GRC.
Gerasimos Tsourouflis2nd Propaedeutic Department of Surgery, Laiko General Hospital of Athens, Athens, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-radiation sarcoma is a rare clinical entity, but it is considered an aggressive late complication of radiotherapy administered as adjuvant therapy for breast cancer treatment. Although radiotherapy significantly improves local disease control and survival, radiation-induced malignancies may occur years after treatment completion. Surgical resection with negative margins remains the cornerstone of management. However, treatment is often challenging because of prior irradiation, local tissue fibrosis, and advanced local disease. We report the case of a 65-year-old woman previously treated for breast cancer with breast-conserving surgery followed by adjuvant chemotherapy and radiotherapy. Twenty-three years after completion of radiotherapy, the patient developed a progressively enlarging mass within the irradiated field. Imaging studies revealed a heterogeneous soft tissue lesion involving the chest wall. Core needle biopsy demonstrated leiomyosarcoma. Following multidisciplinary team discussion, three weeks after the core biopsy, the patient underwent wide en bloc surgical resection with chest wall reconstruction. Histopathological examination of the surgical specimen revealed high-grade undifferentiated pleomorphic sarcoma with negative surgical margins (R0 resection). Postoperative recovery was uneventful. Then the patient received adjuvant chemotherapy and radiotherapy. The patient remains disease-free after three years of follow-up. Post-radiation sarcoma following breast cancer radiotherapy remains a rare and highly aggressive malignancy associated with poor prognosis. Early recognition and aggressive multidisciplinary treatment, particularly complete surgical excision with negative margins, are critical for improving outcomes.

Indexed as

breast cancerchest wall reconstructionpost-radiation sarcomaradiation-induced sarcomaradiotherapysurgical oncology

Identifiers

PMID42438637
PMCPMC13356921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.